Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.

BACKGROUND AND METHODS In an attempt to develop potent antitumor agents, the synthesis of a series of N-(6-substituted benzothiazol-2-yl)-2-[(5-(arylamino)-1,3,4-thiadiazol-2-yl)thio]acetamides (1-14) was described and their cytotoxic effects on A549 human lung adenocarcinoma, MCF-7 human breast adenocarcinoma, HepG2 human hepatocellular carcinoma and NIH/3T3 mouse embryonic fibroblast cell lines were investigated using MTT assay. RESULTS Phenyl-substituted compounds (8-14) were found to be more effective than naphthyl-substituted compounds (1-7) on cancer cells. Compounds 8, 9, 10, 12, 13 and 14 were identified as the most potent anticancer agents on MCF-7 and HepG2 cell lines and therefore their effects on DNA synthesis and apoptosis/necrosis in MCF-7 cell line were evaluated. Among these compounds, N-(6-methoxybenzothiazol-2-yl)-2-[(5- (phenylamino)-1,3,4-thiadiazol-2-yl)thio]acetamide (13) was the most selective anticancer agent against MCF-7 and HepG2 cell lines with a SI value of 100. On the other hand, compounds 8, 9, 10, 12, 13 and 14 inhibited DNA synthesis in MCF-7 cell line in a dose-dependent manner. Flow cytometric analyses clearly indicated that the compounds showed significant anticancer activity against MCF-7 cell line via the induction of apoptosis dose dependently. CONCLUSION According to in vitro assays, compounds 8, 9, 10, 12, 13 and 14 stand out as promising candidates for further studies.

[1]  Z. Kaplancıklı,et al.  Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives. , 2017, Bioorganic & medicinal chemistry.

[2]  Z. Kaplancıklı,et al.  Synthesis and Evaluation of New Thiazolyl Hydrazone Derivatives as Potential Anticancer Agents , 2017 .

[3]  S. Saha,et al.  Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review. , 2017, Anti-cancer agents in medicinal chemistry.

[4]  K. Dawood,et al.  Thiadiazole inhibitors: a patent review , 2017, Expert opinion on therapeutic patents.

[5]  A. Aliabadi 1,3,4-Thiadiazole Based Anticancer Agents. , 2016, Anti-cancer agents in medicinal chemistry.

[6]  S. Ilgın,et al.  Synthesis and biological evaluation of new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer agents. , 2016, European journal of medicinal chemistry.

[7]  Pinaki S. Bhadury and Jun Pang Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores , 2015 .

[8]  J. Matysiak Biological and pharmacological activities of 1,3,4-thiadiazole based compounds. , 2015, Mini reviews in medicinal chemistry.

[9]  C. Tanyeli,et al.  Bioactive thiazole and benzothiazole derivatives. , 2015, European journal of medicinal chemistry.

[10]  N. Jain,et al.  Synthesis and evaluation of benzosuberone embedded with 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole moieties as new potential anti proliferative agents. , 2015, Bioorganic & medicinal chemistry letters.

[11]  S. Ilgın,et al.  A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity. , 2015, European journal of medicinal chemistry.

[12]  H. Hamid,et al.  1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold. , 2015, European journal of medicinal chemistry.

[13]  Rangappa S. Keri,et al.  A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. , 2015, European journal of medicinal chemistry.

[14]  Xiaoyun Fu,et al.  Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety. , 2014, Bioorganic & medicinal chemistry letters.

[15]  Weiping Tang,et al.  Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif. , 2014, Bioorganic & medicinal chemistry.

[16]  H. Temel,et al.  Synthesis and In vitro Evaluation of Thiadiazole Derivatives as AChE, Bu- ChE and LOX Inhibitors , 2014 .

[17]  S. Ilgın,et al.  Synthesis and in Vitro Evaluation of New Nitro-Substituted Thiazolyl Hydrazone Derivatives as Anticandidal and Anticancer Agents , 2014, Molecules.

[18]  Ya-Juan Qin,et al.  Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents. , 2014, Bioorganic & medicinal chemistry.

[19]  Roberto Bianco,et al.  In Vitro and In Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies , 2014, Current medicinal chemistry.

[20]  P. Bedi,et al.  Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. , 2014, European journal of medicinal chemistry.

[21]  Yong-Hua Yang,et al.  1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. , 2014, Chemical reviews.

[22]  A. Aliabadi,et al.  Discovery of 2‐Phenyl‐N‐(5‐(trifluoromethyl)‐1,3,4‐thiadiazol‐2‐yl)acetamide Derivatives as Apoptosis Inducers via the Caspase Pathway with Potential Anticancer Activity , 2013, Archiv der Pharmazie.

[23]  A. Jain,et al.  1,3,4‐Thiadiazole and its Derivatives: A Review on Recent Progress in Biological Activities , 2013, Chemical biology & drug design.

[24]  H. Rajak,et al.  Medicinal significance of benzothiazole scaffold: an insight view , 2013, Journal of enzyme inhibition and medicinal chemistry.

[25]  Yang Liu,et al.  Thiadiazole—a Promising Structure in Medicinal Chemistry , 2013, ChemMedChem.

[26]  W. Rzeski,et al.  2-Amino-1,3,4-thiadiazole derivative (FABT) inhibits the extracellular signal-regulated kinase pathway and induces cell cycle arrest in human non-small lung carcinoma cells. , 2012, Bioorganic & Medicinal Chemistry Letters.

[27]  K. Shah,et al.  A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles as potent cytotoxic agents. , 2012, European journal of medicinal chemistry.

[28]  M. Noolvi,et al.  Benzothiazoles: search for anticancer agents. , 2012, European journal of medicinal chemistry.

[29]  Xuben Hou,et al.  Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors. , 2012, Bioorganic & medicinal chemistry.

[30]  Z. Kaplancıklı,et al.  Synthesis of Some Benzothiazole Based Piperazine-Dithiocarbamate Derivatives and Evaluation of Their Anticancer Activities , 2011 .

[31]  Yan-Bin Zhang,et al.  Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents. , 2011, Bioorganic & medicinal chemistry letters.

[32]  J. Veuthey,et al.  Analysis of anticancer drugs: a review. , 2011, Talanta.

[33]  Fatih Demirci,et al.  Synthesis of Some Novel Triazole Derivatives and Investigation of Their Antimicrobial Activities , 2011 .

[34]  S. Fulda,et al.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.

[35]  A. Westwell,et al.  The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. , 2004, Current medicinal chemistry.

[36]  B. Korkut,et al.  Antiproliferative, Cytotoxic, and Apoptotic Effects of New Benzimidazole Derivatives Bearing Hydrazone Moiety , 2018 .

[37]  Meenakshi Singh,et al.  Benzothiazoles: how relevant in cancer drug design strategy? , 2014, Anti-cancer agents in medicinal chemistry.